Scaling Laws, Rapid Response: An "FDA for AI" at the White House?, with Dean Ball | Lawfare

The upcoming main navigation can be gotten through utilizing the tab key. Any buttons that open a sub navigation can be triggered by the space or enter key. Alan Rozenshtein, Associate Professor of Law at the University of Minnesota and Research Director at Lawfare, and Kevin Frazier, AI Innovation and Law Fellow at the University of Texas School of Law and Senior Editor at Lawfare, spoke with Dean Ball, Senior Fellow at the Foundation for American Innovation and former Senior Policy Advisor for AI at the White House Office of Science and Technology Policy, about the Trump administration's reported plans to vet frontier AI models before public release. They discussed how Anthropic's Mythos model reshaped the administration's posture on AI risk; why the executive branch lacks clear legal authority for a mandatory pre-deployment vetting regime; the voluntary "kick the tires" framework Frazier and Ball have proposed using CAISI and the Cyber Resilience Fund; whether an FDA-style licensing

saved by

• Elizabeth Qiu